TriNetX

Impact: TriNetX acquired key assets of Zetta Genomics, expanding its genomics data management and analytics capabilities, which enhances its ability to integrate multiomic data for clinical research and care delivery.

Impact: TriNetX acquired Cocoon to expand its leave management solutions for small and medium-sized businesses, enhancing its HR offerings with compliance-first products and AI-enabled workflows. The acquisition is not expected to materially impact TriNetX's 2026 financial guidance.

Impact: TriNetX is collaborating with Regeneron Pharmaceuticals to provide secure access to its global network of de-identified health data from approximately 300 million individuals. This collaboration includes an investment of up to $200 million from Regeneron Pharmaceuticals.

Impact: TriNetX is the network from which researchers analyzed electronic health records of over 250 million patients, providing the data infrastructure for the study.

Impact: TriNetX is the global research network that provided the de-identified patient data used in the study to analyze the long-term effects of Melatonin.